9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      PJA1 mediates the effects of astrocytic GPR30 on learning and memory in female mice

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hormone replacement therapy (HRT) is not recommended for treating learning and memory decline in menopausal women because it exerts adverse effects by activating classic estrogen receptors ERα and ERβ. The membrane estrogen receptor G protein-coupled receptor 30 (GPR30) has been reported to be involved in memory modulation; however, the underlying mechanisms are poorly understood. Here, we found that GPR30 deletion in astrocytes, but not in neurons, impaired learning and memory in female mice. Astrocytic GPR30 depletion induced A1 phenotype transition, impairing neuronal function. Further exploration revealed that Praja1 (PJA1), a RING ubiquitin ligase, mediated the effects of astrocytic GPR30 on learning and memory by binding to Serpina3n, which is a molecular marker of neuroinflammation in astrocytes. GPR30 positively modulated PJA1 expression through the CREB signaling pathway in cultured murine and human astrocytes. Additionally, the mRNA levels of GPR30 and PJA1 were reduced in exosomes isolated from postmenopausal women while Serpina3n levels were increased in the plasma. Together, our findings suggest a key role for astrocytic GPR30 in the learning and memory abilities of female mice and identify GPR30/PJA1/Serpina3n as potential therapeutic targets for learning and memory loss in peri- and postmenopausal women.

          Abstract

          Related collections

          Most cited references62

          • Record: found
          • Abstract: found
          • Article: not found

          Neurotoxic reactive astrocytes are induced by activated microglia

          A reactive astrocyte subtype termed A1 is induced after injury or disease of the central nervous system and subsequently promotes the death of neurons and oligodendrocytes.
            • Record: found
            • Abstract: found
            • Article: not found

            Universal sample preparation method for proteome analysis.

            We describe a method, filter-aided sample preparation (FASP), which combines the advantages of in-gel and in-solution digestion for mass spectrometry-based proteomics. We completely solubilized the proteome in sodium dodecyl sulfate, which we then exchanged by urea on a standard filtration device. Peptides eluted after digestion on the filter were pure, allowing single-run analyses of organelles and an unprecedented depth of proteome coverage.
              • Record: found
              • Abstract: found
              • Article: not found

              Astrocytes: biology and pathology

              Astrocytes are specialized glial cells that outnumber neurons by over fivefold. They contiguously tile the entire central nervous system (CNS) and exert many essential complex functions in the healthy CNS. Astrocytes respond to all forms of CNS insults through a process referred to as reactive astrogliosis, which has become a pathological hallmark of CNS structural lesions. Substantial progress has been made recently in determining functions and mechanisms of reactive astrogliosis and in identifying roles of astrocytes in CNS disorders and pathologies. A vast molecular arsenal at the disposal of reactive astrocytes is being defined. Transgenic mouse models are dissecting specific aspects of reactive astrocytosis and glial scar formation in vivo. Astrocyte involvement in specific clinicopathological entities is being defined. It is now clear that reactive astrogliosis is not a simple all-or-none phenomenon but is a finely gradated continuum of changes that occur in context-dependent manners regulated by specific signaling events. These changes range from reversible alterations in gene expression and cell hypertrophy with preservation of cellular domains and tissue structure, to long-lasting scar formation with rearrangement of tissue structure. Increasing evidence points towards the potential of reactive astrogliosis to play either primary or contributing roles in CNS disorders via loss of normal astrocyte functions or gain of abnormal effects. This article reviews (1) astrocyte functions in healthy CNS, (2) mechanisms and functions of reactive astrogliosis and glial scar formation, and (3) ways in which reactive astrocytes may cause or contribute to specific CNS disorders and lesions.

                Author and article information

                Contributors
                Journal
                J Clin Invest
                J Clin Invest
                J Clin Invest
                The Journal of Clinical Investigation
                American Society for Clinical Investigation
                0021-9738
                1558-8238
                15 September 2023
                15 September 2023
                15 September 2023
                : 133
                : 18
                : e165812
                Affiliations
                [1 ]Department of Pharmacology, School of Pharmacy and
                [2 ]Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi’an, China.
                [3 ]Department of Pharmacy, Northwest Women’s and Children’s Hospital, Xi’an, China.
                [4 ]Department of Health Management, Tangdu Hospital, Fourth Military Medical University, Xi’an, China.
                Author notes
                Address correspondence to: Shuibing Liu, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi’an, 710032, China. Email: liushb1974@ 123456aliyun.com . Or to: Minggao Zhao, Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi’an, 710038, China. Email: minggao@ 123456fmmu.edu.cn .

                Authorship note: XW, YJ, and BF contributed equally to this work.

                Author information
                http://orcid.org/0000-0003-3852-6852
                http://orcid.org/0000-0002-6694-988X
                http://orcid.org/0000-0002-9249-5121
                http://orcid.org/0000-0002-7736-4625
                http://orcid.org/0000-0002-7539-3887
                http://orcid.org/0000-0002-9325-3474
                Article
                165812
                10.1172/JCI165812
                10503807
                37712419
                2842870d-633b-415e-952e-649a98e6aa3a
                © 2023 Wang et al.

                This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 10 October 2022
                : 19 July 2023
                Funding
                Funded by: National Natural Science Foundation of China, https://doi.org/10.13039/501100001809;
                Award ID: 82071474,82003734,81771420,31972902
                Funded by: Scientific and Technological Innovation Team of Shaanxi Province
                Award ID: 2023-CX-TD-63
                Funded by: Youth Talent Promotion Program of Shaanxi Association for Science and Technology
                Award ID: 20210306
                Funded by: Natural Science Basic Research Program of Shaanxi Province
                Award ID: 2022JQ-869
                Categories
                Research Article

                inflammation,neuroscience,memory,pharmacology
                inflammation, neuroscience, memory, pharmacology

                Comments

                Comment on this article

                Related Documents Log